In the News
Lisa Dwyer discusses the FDA’s struggle to review Moderna and Merck's mRNA-4157 melanoma cancer vaccine candidate as the companies used artificial intelligence to determine the formulation of the individualized vaccine
May 8, 2024
| InsideHealthPolicy

Go to the article

Explore King & Spalding
a group of blue and white objects
Capabilities
Innovative Drug, Biologic & Device Development
a close up of a circuit board
Capabilities
Artificial Intelligence (AI) & Machine Learning